Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars

NCT: NCT01619917 · RECRUITING

NCT IDNCT01619917
StatusRECRUITING
Start Date2012-11-01
Completion2028-07-01

Brief Summary

While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials. Laser therapy can be quite expensive when compared to other treatment modalities for burn scars, and while promising, its true usefulness has yet to be conclusively demonstrated. For this reason, our assessing the effects of fractional vascular lasers on burn scars. It has been hypothesized that the fractional vascular lasers work on mature scars to decrease scar formation, and the fractional laser works on scar that is quiescent to promote remodelling. The retexturing/ resurfacing of the laser theoretically can decrease the visibility of the mesh pattern created by meshed split thickness skin graft). Objective: To determine the benefit of fractional vascular laser treatment in improving burn scar height, texture, vascularity and pliability in late burn scars.

Frequently Asked Questions

What is The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars?

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars is a clinical trial registered under NCT01619917. Current status: RECRUITING.

What is the status of NCT01619917?

The current status of NCT01619917 (The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars) is: RECRUITING.

When did The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars start?

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars started on 2012-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.